Literature DB >> 16624810

The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.

Andrew M Ellisdon1, Bronwen Thomas, Stephen P Bottomley.   

Abstract

The aggregation of ataxin-3 is associated with spinocerebellar ataxia type 3, which is characterized by the formation of intraneuronal aggregates. However, the mechanism of aggregation is currently not well understood. Ataxin-3 consists of a folded Josephin domain followed by two ubiquitin-interacting motifs and a C-terminal polyglutamine tract, which in the non-pathological form is less than 45 residues in length. We demonstrate that ataxin-3 with 64 glutamines (at(Q64)) undergoes a two-stage aggregation. The first stage involves formation of SDS-soluble aggregates, and the second stage results in formation of SDS-insoluble aggregates via the poly(Q) region. Both these first and second stage aggregates display typical amyloid-like characteristics. Under the same conditions at(Q15) and at(QHQ) undergo a single step aggregation event resulting in SDS-soluble aggregates, which does not involve the polyglutamine tract. These aggregates do not convert to the SDS-insoluble form. These observations demonstrate that ataxin-3 has an inherent capacity to aggregate through its non-polyglutamine domains. However, the presence of a pathological length polyglutamine tract introduces an additional step resulting in formation of a highly stable amyloid-like aggregate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624810     DOI: 10.1074/jbc.M601470200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

3.  Orthogonal cross-seeding: an approach to explore protein aggregates in living cells.

Authors:  Justyna Hinz; Lila M Gierasch; Zoya Ignatova
Journal:  Biochemistry       Date:  2008-03-11       Impact factor: 3.162

4.  Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies.

Authors:  Joseph P Bernacki; Regina M Murphy
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

5.  Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach.

Authors:  Matthias Michalek; Evgeniy S Salnikov; Burkhard Bechinger
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

6.  Direct characterization of amyloidogenic oligomers by single-molecule fluorescence.

Authors:  Angel Orte; Neil R Birkett; Richard W Clarke; Glyn L Devlin; Christopher M Dobson; David Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

7.  Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy.

Authors:  Lauren E Buchanan; Joshua K Carr; Aaron M Fluitt; Andrew J Hoganson; Sean D Moran; Juan J de Pablo; James L Skinner; Martin T Zanni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

8.  PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner.

Authors:  Na-Li Jia; Er-Kang Fei; Zheng Ying; Hong-Feng Wang; Guang-Hui Wang
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

9.  Polyalanine expansions drive a shift into α-helical clusters without amyloid-fibril formation.

Authors:  Saskia Polling; Angelique R Ormsby; Rebecca J Wood; Kristie Lee; Cheryl Shoubridge; James N Hughes; Paul Q Thomas; Michael D W Griffin; Andrew F Hill; Quill Bowden; Till Böcking; Danny M Hatters
Journal:  Nat Struct Mol Biol       Date:  2015-11-16       Impact factor: 15.369

10.  Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.

Authors:  Erik Kvam; Brent L Nannenga; Min S Wang; Zongjian Jia; Michael R Sierks; Anne Messer
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.